Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/SMMT
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Summit Therapeutics Inc (SMMT) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Summit Therapeutics (SMMT) trades at $13.105, down 4.06% today, amid bearish technical signals and negative profitability metrics. The company reported a Q2 2026 loss of $0.28 per share, missing expectations, while advancing its lead candidate ivonescimab through late-stage trials. Cash flow remains negative from operations, offset by financing activities. Analyst consensus is bullish with a $24.54 price target, but the stock faces headwinds from going concern risks and high volatility.
Outlook hinges on FDA approval for ivonescimab by November 2026, with recent partnerships and survival data offering catalysts. However, persistent losses, cash burn, and binary regulatory outcome pose significant risks. Investors should weigh high-reward potential against substantial downside if clinical or regulatory setbacks occur.
Read full analysis

Key Stats

  • Market Cap
    $10.45B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $29.32
  • 52W Low
    $13.05
  • Typical Hold Time
    -
  • Enterprise Value
    $9.78B
  • Div Yield
    -
  • Trading Activity
    -
$12.38
52W Low: $12.38
28 Jul 2026
52W High: $29.32
04 Aug 2025

Track Summit Therapeutics Inc (SMMT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $12.38 and a high of $29.32, highlighting its annual price range. Buy and sell Summit Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Summit Therapeutics Inc

Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.

Most Recent News

Content is generated by Aura AI

Blink Charging gets 180-day extension to meet Nasdaq's minimum bid price rule.

Blink Charging Co. has been granted an additional 180 days, until January 25, 2027, by Nasdaq to comply with the minimum bid price requirement for listing. The company had requested this extension as it meets other Nasdaq Capital Market listing stand...

Market News
1 hour ago
Na
Neutral
pluang ai news

CRCAM Alpes Provence releases financial report for June 30, 2026, available online and filed with regulators

CRCAM Alpes Provence has published its financial report as of June 30, 2026. The document is accessible on their official website and has been submitted to the French financial regulator, the Autorité des Marchés Financiers. This release ensures tran...

Market News
1 hour ago
Na
Neutral
pluang ai news

Investigation launched into T1 Energy over possible securities violations after cost overruns and delays.

Block & Leviton LLP is investigating T1 Energy for potential securities law violations following the company's announcement of a 20% increase in capital expenditures and delays in its solar-cell project. The investigation centers on whether T1 Energy...

Market News
2 hours ago
Block & Leviton Llp
Bearish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $10.45B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $29.32
  • 52W Low
    $13.05
  • Typical Hold Time
    -
  • Enterprise Value
    $9.78B
  • Div Yield
    -
  • Trading Activity
    -
$12.38
52W Low: $12.38
28 Jul 2026
52W High: $29.32
04 Aug 2025

Track Summit Therapeutics Inc (SMMT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Summit Therapeutics Inc has traded between a low of $12.38 and a high of $29.32, highlighting its annual price range. Buy and sell Summit Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!